+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer



Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer



Wiener Medizinische Wochenschrift 155(19-20): 429-435



For early diagnosis of thyroid cancer, ultrasonography (US) and US-guided fine-needle aspiration biopsy are the methods of choice. Thyroid scintigraphy using Tc-99m pertechnetate can underline the necessity of surgery in case of hypofunctioning nodules. Treatment of thyroid cancer includes total thyroidectomy and staging lymphadenectomy, in the case of lymph node metastases, radical neck dissection of the ipsilateral side. Four weeks after surgery, if TSH exceeds a value of 50 mU/l, with the exception of papillary thyroid cancer pT1a (TNM 1997), radioiodine remnant ablation using activities between 2960 and 3700 MBq I-131 is performed in all other cases. As growth of benign and malignant thyroid cells depends on TSH stimulation, thyroid hormone therapy using TSH suppressive doses (TSH, <0.03 mU/l) follows radioiodine remnant ablation. Additional fractionated external radiation therapy (50 Gy) may be administered in advanced cases (e.g., pT4 N1M0; TNM 1997). Standard follow-up of differentiated thyroid cancer includes measurement of serum thyroglobulin, US of the neck and I-131 whole-body scintigraphy (I-131 WBS). With about 98% the sensitivity of thyroglobulin is very high under TSH stimulation. In case of elevated thyroglobulin, US is the method of choice to detect local recurrences and lymph node metastases of the neck. At defined intervals of follow-up or in case of increasing thyroglobulin, I-131 WBS will be performed under TSH stimulation. With the availability of recombinant TSH (exogenous TSH stimulation) the need to withdraw thyroid hormone over a period of 3-4 weeks (endogenous TSH stimulation) is no longer necessary to perform I-131 WBS. However, in about 20-40% of cases or in the course of disease after several radioiodine therapies, recurrences or metastases may be or become iodine negative. In this case, cationic complexes such as Tc-99m Sestamibi or Tc-99m Tetrofosmin are available to detect less differentiated metastases. In the course of dedifferentiation of malignant thyroid cells, the ability of iodine uptake decreases and uptake of glucose increases. This elevated glucose metabolism can be imaged using FDG PET. Today the combination of PET (metabolic imaging) and CT (morphologic imaging) using PET/CT fusion imaging is the method of choice to image iodine-negative metastases.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048776312

Download citation: RISBibTeXText

PMID: 16424998

DOI: 10.1007/s10354-005-0219-8


Related references

Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology 20(Suppl. 4): 143-146, 2009

Differentiated thyroid cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Annals of Oncology 19(Suppl. 2): Ii99, 2008

Summary of the Israeli Endocrine Society's consensus statement on the diagnosis, treatment and follow-up of well-differentiated thyroid cancer. Harefuah 147(10): 825-32, 836, 2008

Use of Radiopharmaceuticals for Diagnosis, Treatment, and Follow-Up of Differentiated Thyroid Carcinoma. Anti-Cancer Agents in Medicinal Chemistry 7(4): 399-409, 2007

Use of radiopharmaceuticals for diagnosis, treatment, and follow-up of differentiated thyroid carcinoma. Anti-Cancer Agents in Medicinal Chemistry 7(4): 399-409, 2007

Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up. Cancer 57(7): 1405-1414, 1986

Role of chest radiography in the diagnosis and follow-up of pulmonary metastasis in differentiated thyroid cancer. Journal of the Medical Association of Thailand 93(Suppl. 3): S52-S60, 2010

99mTc-SESTAMIBI usefulness in the follow-up of differentiated thyroid cancer Case report. Biomedicine & Pharmacotherapy 47(6-7): 253, 1993

Current Guidelines for Postoperative Treatment and Follow-Up of Well-Differentiated Thyroid Cancer. Surgical Oncology Clinics of North America 25(1): 41-59, 2016

Long term follow up of medical treatment of differentiated thyroid cancer. Annales d'Endocrinologie 56(2): 119-126, 1995

Is there survival benefit from life-long follow-up after treatment for differentiated thyroid cancer?. International Journal of Surgery 11(2): 116-121, 2013

Advancements in the diagnosis and treatment of differentiated thyroid cancer. Clinical Medicine and Research 1(1): 3, 2003

Update on the diagnosis and treatment of differentiated thyroid cancer. Quarterly Journal of Nuclear Medicine and Molecular Imaging 53(5): 465-472, 2009

Advancements in the Diagnosis and Treatment of Differentiated Thyroid Cancer. Clinical Medicine & Research 1(1): 3-3, 2003

Early diagnosis and differentiated treatment of thyroid cancer. Khirurgiia 2000(3): 38-41, 2000